1. Identify a third option (after melatonin and clonazepam) for RBD treatment;
2. Help patients understand their risk for neurodegenerative disease; and
3. Identify a multisite clinical trial (the NAPS trial) for patients with RBD.”
- Provider:American Academy of Sleep Medicine
- Activity Link: https://members.aasm.org/site/AASMMembers/AASMStore/StoreLayouts/Store_Home.aspx?_ga=2.268336585.617269933.1678726775-1341211529.1652816181
- Start Date: 2023-03-24 05:00:00
- End Date: 2023-03-24 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.75 hours
- MOC Credit Details: ABIM - 0.75 Point; Credit Type(s): Medical Knowledge (ABIM)
ABP - 0.75 Point; Credit Type(s): Lifelong Learning and Self-Assessment (ABP)
ABOHNS - 0.75 Point; Credit Type(s): Self-Assessment (ABOHNS) - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Competence, Learner Knowledge
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Sleep Medicine
Subscribe
Login
0 Comments
Oldest